Proteomics 2020 | Zurich | Switzerland | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Multidisciplinary Approaches in Biochemistry Research

- Proteomics 2020

Welcome Message

AAC is delighted to welcome you to the 5th International Conference on Proteomics, Genomics, and Molecular Medicine, scheduled on March 09-10, 2020 in Zurich, Switzerland.

Proteomics Congress works on the theme “Current Trends and Innovations in Proteomics, Genomics and Molecular Medicine” which encompasses Keynote presenters, establishers, Delegates, and Speakers.

Reach out to potential experts and break through the excellence of understanding the innovations in Proteomics, Genomics, and Molecular Medicine.

It provides an interdisciplinary platform and valuable recognition for Speakers and Poster presenters to present and discuss the recent trends, innovations, and practical challenges encountered and the solutions adopted in this field.

We are confident that your knowledge, participation, and expectations will help us achieve our goals.

To explore the Proteomics, Genomics, and Molecular Medicine field and all resources we would like to share with you, please join us in London.

We hope you will join us to make Proteomics Conferences a memorable event!

Thank you for your attention and collaboration!

Yours Sincerely,

Proteomics Conference 2020 | Committee Members

Market Analysis

The field of proteomics and genomics has been witnessing significant growth over the past few years, primarily due to advances in technology, rising demand for personalized medicines, and increasing investments in R&D activities. Proteomics is the study of proteins and their functions, whereas genomics is the study of genes and their functions. Together, these two fields play a crucial role in understanding the genetic basis of diseases and developing new treatments. In this report, we will provide a global market analysis of proteomics and genomics, including data interpretations and future growth prospects.

Market Overview:

According to a report by MarketsandMarkets, the global proteomics market size is expected to reach $38.7 billion by 2025, growing at a CAGR of 14.5% during the forecast period. The increasing demand for personalized medicine, rising R&D activities, and the growing importance of proteomics in drug discovery and development are the major factors driving the growth of the market.

The genomics market, on the other hand, is expected to reach $32.9 billion by 2026, growing at a CAGR of 11.7% during the forecast period, according to a report by Allied Market Research. The growing prevalence of genetic diseases, increasing demand for precision medicine, and technological advancements in sequencing and analysis are the major factors driving the growth of the market.

Global Market Analysis:

North America dominates the global proteomics and genomics market, owing to the presence of a large number of key players, increasing R&D activities, and favourable government initiatives. According to a report by ResearchAndMarkets, the North American proteomics market is expected to reach $16.3 billion by 2025, growing at a CAGR of 14.2% during the forecast period. The US is the largest market for proteomics in North America, owing to the presence of major pharmaceutical companies, government initiatives, and increasing R&D activities.

Similarly, the North American genomics market is expected to reach $14.9 billion by 2026, growing at a CAGR of 11.6% during the forecast period, according to a report by Allied Market Research. The US dominates the genomics market in North America, owing to the presence of major players, increasing investments in R&D, and favourable government initiatives.

The global market for proteomics and genomics is expected to grow at a CAGR of around 14% from 2021 to 2028, driven by factors such as the increasing demand for personalized medicine, the rising prevalence of chronic diseases, and advancements in technology. In 2020, the market was valued at USD 24.8 billion and is expected to reach USD 65.5 billion by 2028.

Europe is the second-largest market for proteomics and genomics, owing to the increasing prevalence of genetic diseases, rising demand for personalized medicine, and growing investments in R&D activities. According to a report by Allied Market Research, the European proteomics market is expected to reach $10.8 billion by 2026, growing at a CAGR of 13.4% during the forecast period. The UK, Germany, and France are the major markets for proteomics in Europe, owing to the presence of major players and increasing investments in R&D.

Similarly, the European genomics market is expected to reach $8.7 billion by 2026, growing at a CAGR of 11.5% during the forecast period, according to a report by Allied Market Research. The UK, Germany, and France dominate the genomics market in Europe, owing to the presence of major players and increasing investments in R&D activities.

Asia Pacific is expected to witness significant growth in the proteomics and genomics market, owing to the increasing prevalence of genetic diseases, rising demand for personalized medicine, and growing investments in R&D activities. According to a report by Markets, the Asia Pacific proteomics market is expected to reach $9.2 billion by 2025, growing at a CAGR of 15.3% during the forecast period. China and Japan are the major markets for proteomics in the Asia Pacific, owing to the presence of major players and increasing investments in R &D activities.

Similarly, the Asia Pacific genomics market is expected to reach $8.4 billion by 2026, growing at a CAGR of 12.6% during the forecast period, according to a report by Allied Market Research. China and India are the major markets for genomics in the Asia Pacific, owing to the increasing prevalence of genetic diseases and growing investments in R&D activities.

Market Segmentation:

The proteomics market can be segmented based on technology, application, and region. Based on technology, the market can be segmented into protein microarrays, spectroscopy, chromatography, electrophoresis, protein fractionation, X-ray crystallography, and others. Based on application, the market can be segmented into drug discovery and development, diagnostics, clinical research, and others.

Similarly, the genomics market can be segmented based on technology, product, application, and region. Based on technology, the market can be segmented into sequencing, microarray, PCR, and others. Based on product, the market can be segmented into instruments, consumables, and services. Based on application, the market can be segmented into diagnostics, drug discovery and development, personalized medicine, and others.

Future Growth Prospects:

The global proteomics and genomics market is expected to witness significant growth in the coming years, primarily due to the increasing demand for personalized medicine, rising R&D activities, and growing investments in technology. The market is also witnessing significant advancements in sequencing and analysis, which is expected to further drive the growth of the market.

In conclusion, the proteomics and genomics market is witnessing significant growth, primarily due to the increasing demand for personalized medicine, rising R&D activities, and growing investments in technology. The market is dominated by North America, followed by Europe and Asia Pacific. The market can be segmented based on technology and application, while some of the key players in the market include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc., and Waters Corporation. The market is expected to witness significant growth in the coming years, owing to the increasing advancements in sequencing and analysis.

Session Tracks

1. Session on Proteomics

Proteomics is the scientific discipline that studies and searches for proteins that are associated with the disease using their altered levels of sequence. Each level of protein structure is essential for the finished molecule’s function. The focus of Proteomics is a biological group called proteome (set of protein sequences). Proteomics Conferences 2023 will elaborate on Proteomics.

Structural Proteomics
Expression Proteomics
Functional Proteomics
Protein Expression
Protein interactions
Post-translational modifications
Metabolic Pathways

Related Associations: Turkish Proteomics Association, Serbian Proteomics Association, Italian Proteomics Association, European Proteomics Association, Czech Republic Proteomics Association, Belgian Proteomics Association, Austrian Proteomics and Metabolomics Association, US Human Proteome Organization.

Related Societies: Spanish Proteomics Society, Swedish Genomics Society, Proteomics Society of India, Iranian Proteomics Society, Japanese Proteomics Society, Malaysian Proteomics Society, Pakistan Proteomics Society, Taiwan Proteomics Society.

Related Journals: Journal of Proteomics & Bioinformatics, Journal of Proteomics and Genomics Research, International Journal of Genomics and Proteomics, Journal of Data Mining in Genomics & Proteomics, International Journal of Proteomics, Briefings in Functional Genomics, Proteomics Insights Stem book, The Open Proteomics Journal.

2. Session on Molecular Biology and Genetics

Molecular Biology and Genetics pursue understanding how the molecules that make up cells determine the behaviour of living things. Biologists use molecular and genetic tools to study the functions of those molecules in the complex milieu of the living cell. Proteomics Conferences 2023 will elaborate on

Molecular Genetics
Gene Therapy
Comparative Genomics
PharmacoGenomics
Gene Modifications

3. Session on Bioinformatics

Bioinformatics is a sub-discipline of biology and computer science concerned with the acquisition, storage, analysis, and dissemination of biological data, most often DNA and amino acid sequences. Bioinformatics uses computer programs for a variety of applications, including determining gene and protein functions, establishing evolutionary relationships, and predicting the three-dimensional shapes of proteins. It is the process by which biological problems posed by the assessment or study of bio-data are interpreted and analyzed. Bioinformatics professionals develop algorithms, programs, codes, and analytic models to record and store data related to biology. This includes the study of the human genome, biochemical proteins, pharmacological ingredients, metabolic pathway readings, etc. Proteomics Conferences 2023 will elaborate on

Biotechnology
Personalized Medicine
Preventive Medicine
Molecular medicine
Antibiotic Resistance
Microbial Genome Application
Crop Improvement
Drug Development
Machine Learning

4. Session on Computational Biology

Computational Biology is concerned with the solutions to issues that have been raised by studies in bioinformatics. Computational biology has been used to build highly-detailed models of the human brain, map the human genome, and assist in the modelling of biological systems. Computational biology researchers develop and implement algorithms and tools that address biological questions, concerns, or challenges that have been raised by bioinformatic analyses. Proteomics Conferences 2023 will elaborate on,

Computational Bioengineering
Computational Biomechanics
Computational Bioimaging
Mathematical Biology
Evolutionary Genomics and Proteomics
Population Genomics
Biomedical Image Analysis and modelling

5. Session on Structural Proteomics

Structural Proteomics is the application of protein chemistry and modern mass spectrometric techniques to problems such as the characterization of protein structures and assemblies and the precise determination of protein-protein interactions. Proteomics Conferences 2023 will elaborate on

Cross Linking
Photo Affinity Labelling
Limited Proteolysis
Chemical Protein Modification
Mass Spectrometric Exchange

6. Session on Functional Proteomics

This area of Proteomics is focused on identifying the biological functions of specific individual proteins, classes of proteins (e.g. Kinases), or whole protein interaction networks. It also includes the isolation of protein complexes or the use of protein ligands to isolate specific types of proteins. It allows selected groups of proteins to be studied its characteristics which can provide important information about protein signalling and disease mechanism etc. Proteomics Conferences 2023 will elaborate on Functional Proteomics.

7. Session on Proteome Mining

proteome mining is a functional proteomic approach that is used to extract information from the analysis of specific sub-Proteomics. In principle, it is based on the assumption that all drug-like molecules selectively compete with a natural cellular ligand for a binding site on a protein target. Proteomics Conferences 2023 will elaborate on

Drug Discovery
Drug Targets
Enzymes
Tandem Mass Spectrometry

8. Session on Bio-Medical Applications of Proteomics

The applications of Proteomics in the discovery of new diagnostic, prognostic and therapeutic targets cover a wide range of example applications for the most important diseases, such as heart and cardiovascular disorders, cancer, pharm toxicology, infectious diseases, and also diseases of the nervous system. Proteomics Conferences 2023 will elaborate on

Biological Pathways
Clinical Markers
Clinical Proteomics

9. Session on Animal Proteomics

Animal or veterinary Proteomics is an evolving field that holds great promise not only for fundamental and applied discoveries regarding the biology and pathology of domestic species but can also be implemented in the comparative applications of human diseases research. While there are certain technical limitations in the expansion of the field, they can currently be circumvented and in the future can be mastered with greater participation of the proteomic experts, which will in turn drive the accessibility of species-specific reagents, data volume expansion in bioinformatic databases, and increased funding. Proteomics Conferences 2023 will elaborate on

Animal Fluid Proteomics
Animal proteins
Drug Testing

10. Session on Epigenetics

Epigenetics is the study of how your behaviour and environment can cause changes that affects the way your genes work. Unlike genetic changes, epigenetic modifications are reversible and do not change your DNA sequence, but they can change how your body reads a DNA sequence. Gene expression refers to how often proteins are created from the instructions within your genes. Genetic changes can alter which protein is made, whereas epigenetic changes affect gene expression to turn genes “on” and “off.” Proteomics Conferences 2023 will elaborate on

DNA Methylation
histone Modifications
Non-Coding RNA

11. Session on Epigenomics

Epigenomics Is the study of all epigenetic changes in the cell the epigenome is a multitude of chemical compounds that instruct the genome what to do. The human genome is a complete assembly of DNA about 3 billion base pairs that make each unique. DNA holds the instructions for building proteins that carry out a variety of functions in a cell. The epigenome is made up of chemical compounds and proteins that attach themselves to the DNA and direct actions such as turning genes on or off and controlling the protein production in particular cells. When some epigenomic compounds bind themselves to the DNA they modify its functions and they mark the genome. These marks will not change the sequence of the DNA. But, they change the way these cells use the DNA's instructions and these marks are sometimes passed on from cell to cell as cells divide. There are chances they can be passed down from one generation to the next. Proteomics Conferences 2023 will elaborate on Epigenetics.

12. Session on Protein Biochemistry and Proteomics

Based on research certain genes, molecules and cellular functions may become abnormal in the case of a disease such as cancer. Protein Biochemistry aims at diagnosing and manipulating molecular processes underlying diseases. Molecular medicine attributes have five different but often interconnected goals. These goals include diagnosing the disease earlier, Improving the reliability of prognosis, Improving the effectiveness of therapies, Reducing invasiveness, and Monitoring health, and personalized, medications. Proteomics Conferences 2023 will elaborate on Biochemistry and Proteomics.

13. Session on Protein Interactions in Systems Biology

Protein-protein interactions (PPIs) handle a wide range of biological processes, including cell-to-cell interactions and metabolic and developmental control. Protein-protein interaction is becoming one of the major objectives of system biology. Noncovalent contacts between the residue side chains are the basis for protein folding, protein assembly, and PPI. These contacts induce a variety of interactions and associations among the proteins. The Cell Signaling Systems and networks will be studied through systems' biology thanks to the Inherent complexity of signalling networks, quantity, and form of Quantitative information. The big selection of stimulus-response behaviour is noticed in cells that are central to all or any of Biology through cell signalling. Cell signalling systems principally receive input from the surroundings and then generate an output response supported by the received input. Supported by the Physio-Chemical Principles, Physical Interaction Networks will outline the Interacting super molecule Pairs. This kind of matrix assists links between structural biology and system biology. Proteomics Conferences 2023 will elaborate on

Metabolic Networks
Somatic cell Network
Protein DNA interactions

14. Session on Quantitative Proteomics

Quantitative Proteomics is a powerful approach used for both the discovery and targeted proteomic analyses to understand global proteomic dynamics in a cell, tissue, or organism. Most quantitative proteomic analyses entail the isotopic labelling of proteins or peptides in the experimental groups, which can then be differentiated based on mass spectrometry. Relative quantitation methods (SILAC, ICAT, ICPL, and isobaric tags) are used to compare protein or peptide abundance between samples while spiking the unlabeled samples with known concentrations of isotopically-labelled synthetic peptides can yield absolute quantification of target peptides via Selected reaction monitoring(SRM). Proteomics Conferences 2023 will elaborate on Quantitative Proteomics.

15. Session on Mass Spectrometry in Proteomics

Mass Spectrometry has become a powerful tool in Proteomics research to precisely determine the molecular mass of peptides, proteins, and sequences. In tandem mass spectrometry, the fragmentation of peptides and proteins gives sequence information for protein identification and for the identification and localization of post-translational or other covalent modifications. Mass determination and the Characterization of proteins can be done through Mass Spectrometry. For the Ionization of proteins in Mass Spectrometry, two methods are used. The methods used are Electrospray Ionization and matrix-assisted laser desorption/Ionization. The top-down approach and Bottom-up approach are used for the analysis of protein. Proteomics Conferences 2023 will elaborate on

Tandem Mass Spectrometry
Targeted Mass Spectrometry
Plasma Mass Spectrometry
Gas Source Spectrometry
Accelerator Spectrometry

16. Session on Genomics

An organism's complete set of DNA is called its genome. Normally every single cell in the human body contains a complete copy of the approximately 3 billion DNA base pairs, or letters, that make up the human genome. Genomics includes the scientific study of complex diseases such as heart disease, asthma, diabetes, and cancer because these diseases are generally caused more by a combination of genetic and environmental factors than by individual genes. Genomics is offering new possibilities for therapies and treatments for some complex diseases and also new diagnostic methods. Proteomics Conferences 2023 will elaborate on

Human genome project
Gene Splicing
Site Specific Mutations
Induced Mutations

17. Session on Structural Genomics

Structural Genomics is the study that attempts to sequence the whole genome and mapping of the genome. Therefore, structural Genomics is mainly concerned with sequencing and genome. The success of structural Genomics initiatives requires the development and application of tools for structure analysis, prediction, and annotation. Proteomics Conferences 2023 will elaborate on

De novo Method
Ab initio Method
Threading
Sequence-based modelling
Structure-based functional analysis
Homology modelling
A computational method for structural analysis
Applications

18. Session on Functional Genomics

Functional Genomics is the study that attempts to determine the function of gene products encoded by the genome of an organism .functional Genomics is mainly concerned with the study of the expression and function of the genome. Proteomics Conferences 2023 will elaborate on

Metabolomics
Transcriptomics
Epigenetics

19. Session on Next-generation sequencing

Next-generation sequencing(NGS) is a technology used for determining the sequence of DNA or RNA to study the genetic variation associated with diseases or any other biological phenomena. NGS enables the interrogation of hundreds to thousands of genes at one time in multiple samples, it also allows the discovery and analysis of the different types of genomic features in a single sequencing run right from a single nucleotide variant (SNVs) to the copy number and structural variants and even RNA fusions. Proteomics Conferences 2023 will elaborate on next-generation sequencing.

20. Session on Integrating Transcriptomics And Genomics

Transcriptomics is defined as the study of transcriptome – the complete set of RNA, also known as expression profiling, as it is the study of expression levels of mRNA in a given cell population. any studies of the transcriptome focus on messenger (m)RNA molecules only, which reflect the genes that are being actively expressed (as protein products) in a cell or tissue at a given time or in a given situation. However, over 95%of the RNAs in a cell are not translated into a protein, so transcriptomics also includes the study of these non-coding RNAs, which have a dizzying variety of forms and functions. Complementing genome sequences with deep transcriptome and proteome data could enable more accurate assembly and annotation of newly sequenced genomes. The protein network is essential to know the function of highly complex eukaryotic tissues like the Human Brain. Bimolecular Interaction detection, a section of functional Proteomics Intentio, assists interaction, assists interaction, assists interaction, assists interaction patterns present within a protein network. Bimolecular Interaction contains a variety of methods. Proteomics Conferences 2023 will elaborate on Integrating Transcriptomic and Genomics.

21. Session on Pharmacogenomics

Pharmacogenomics is the study of how genes can affect a person’s response to drugs. This relatively new field combines pharmacology(the science of drugs acting on biological systems and how the body responds to the drug) and Genomics (the study of genes and their interactions and functions) to develop effective yet safe medications and doses that will be tailored to a person’s genetic makeup. Proteomics Conferences 2023 will elaborate on

Pharmacogenomics for cardiovascular diseases.
Pharmacogenomics for obesity
Pharmacogenomics for diabetes
Predictive prescribing
Drug discovery technologies
Limitations of Pharmacogenomics

22. Session on Metabolomics

Metabolomics is one of the newest ‘omics’ sciences. The metabolome refers to the complete set of low molecular weight compounds in a sample. These compounds are the substrates and by-products of enzymatic reactions and have a direct effect on the phenotype of the cell. Thus, metabolomics aims at determining a sample’s profile of these compounds at a specified time under specific environmental conditions. Metabolomics can be used to determine differences between the levels of thousands of molecules in a healthy and diseased plant. The technology can also be used to determine the nutritional difference between traditional and genetically modified crops, and in identifying plant defence metabolites. Proteomics Conferences 2023 will elaborate on

Pharmacology
Toxicology
Tools for Functional Genomics
Markers of diseases
Transplants

23. Session On Proteomics in Nephrology

Omics studies have the potential to unravel new disease pathways and thereby allow the development of novel targeted therapies. This is particularly challenging in complex and multifactorial diseases such as DKD with enormous heterogeneity between patients. In Nephrology, rooted renal disorders with the primary renal environment, including cystic renal disorders, renal tubular disease, primary glomerular diseases, and rooted renal neoplasms have been described based on genetic analysis. Urinary proteins on the 2D gel using a dye precipitation method can be analyzed based on proteomic analysis of the urine. Proteomics Conferences 2023 will elaborate on Proteomics in Nephrology.

24. Session On Cardiovascular Proteomics

Cardiovascular Proteomics is an emerging field and significant progress has been made during the past few years to define novel candidate biomarkers and obtain insight into molecular pathophysiology. Omics approaches, including Genomics, transcriptomics, Proteomics, and metabolomics, exploit genome information and use high-throughput analysis techniques. Because the data are comprehensive and the measurements are performed in parallel (i.e., reducing intraassay variability), it lends itself to interrogation by bioinformatic tools that provide objective “unbiased”/“unsupervised” assessment of pertinent features, functional clusters, interactions, and regulatory networks. Proteomic approaches are unequivocally powerful tools that may provide a deeper understanding of the molecular mechanisms associated with cardiovascular disease and improve its management. Proteomics Conferences 2023 will elaborate on Cardiovascular Proteomics.

25. Session on Human Brain Proteome

In all vertebrates and most Invertebrate animals Brain is the organ that acts as the centre of the Nervous System. To research the related diseases and molecular mechanism of the Brain, we gathered various tissue samples and also analyzed the iTRAQ C-based Quantification proteome. The cerebral cortex present in the Human Brain contains Billions of neurons that are connected by synapses to other neurons. The Brain Function can be understood as an Implementation of algorithms and also as an information flow. Proteomics Conferences 2023 will elaborate on the Human Brain proteome.

26. Session on Cancer Proteome And Biomarkers

Proteomics technologies are used for the early detection and diagnosis of cancers and the development of novel therapeutic agents. Identification of biomarkers and also the study of protein expression of the cancer are studied through certain Proteomics platforms. These studies have led to the development of the discovery of new drugs and targeted therapeutics for tumour cells. Detection, prognosis, diagnosis, and therapy of breast cancer are now possible with advancements in the field of Proteomics and mass spectrometry. The discovery of the protein patterns has enabled researchers to distinguish between the disease and disease free-state associated with breast cancer. This discovery leads to personalized and customized therapy for the patients. Proteins that are expressed or found in the serum, plasma, and tumour cells using the novel methodologies provide a better view of the heterogeneity of the cancers. Proteomics Conferences 2023 will elaborate on

Breast Cancer Proteomics
Skin Cancer Proteomics
Lung Cancer Proteomics
Ovarian Cancer Proteomics
Colorectal Cancer Proteomics

27. Session on Molecular Medicine and Diagnostics

Molecular diagnostics is the application of molecular biology techniques to medical testing of patients and/or patient samples to diagnose and monitor diseases, identify risk factors, and define the best therapies for individual patients. The use of molecular biology techniques to analyze biological markers in the human genome and proteome enables the understanding of how individual genetic code is expressed in cells to proteins. Molecular diagnostics is vital to the analysis and management of personalized medicine. In the molecular diagnostics section, we deal with a broad spectrum of innovative biomedical topics and human diseases. Our topics cover a large array of human disorders comprising genetic inborn errors in congenital diseases, cardiovascular disease, neurodegenerative disease, diabetes, obesity, metabolic syndrome, autoimmunity, immune function, and immune system disorders, infectious diseases, haematology, oncogenes in tumour development, and pharmacoGenomics. We welcome your submission, appreciate your interest, and value your contribution. Proteomics Conferences 2023 will elaborate on

Molecular medicine
Precision medicine
Biological markers
congenital diseases
Diabetes, obesity, and metabolic syndrome
Autoimmunity
Immune function and system disorders
Mitochondrial diseases
Infectious diseases
Haematology
Oncogenes
Enzyme Nanotechnology.

28. Session on Microbial Genomics

Microbial Genomics is essentially the identification and characterization of the genetic compositions of microbes. The ability to process and analyze the genomic data collected from microbial organisms is a cornerstone of modern bioinformatics. Proteomics Conferences 2023 will elaborate on Microbial Genomics.

29. Session on Legal and Ethical issues

Reaping the benefits of Proteomics requires us to attend to issues that extend beyond technology. As with most activities concerning health and well-being, the broad inferential powers of Proteomics come with related ethical issues and responsibilities. Many of these, including the importance of informed consent and security, are familiar from other biomedical and human subject-related fields. However, the capacity of proteomic profiles to broadly reflect an individual´s biological state rephrases old questions relating to the types of information that can be derived, regardless of the purpose for which the information was originally collected. Proteomics Conferences 2023 will elaborate on the legal and ethical issues of Proteomics.

30. Session on Proteomics in Healthcare

Proteomics is helping revolutionize the healthcare industry. It is used in biomarker discovery. This has helped in treating, many diseases like cardiovascular diseases, kidney diseases, cancers, etc. Proteomics Conferences 2023 will elaborate on Proteomics in Healthcare.

About Conference

Join all major influencers of Proteomics, Genomics, Molecular Biology, and Medicine at our CPD Accredited: 5th International Conference on Proteomics, Genomics, and Molecular Medicine on October 09-11, 2023 in Paris, France.

Abstract Submission and Registration Are Open!

We intend to gather experts in Proteomics, Genomics, and Molecular Medicine into a single hub to present their cutting-edge research.

We assure you that this conference addresses eminent talks, discussions, and advances. This conference will enrich your knowledge in the field of Proteomics, Genomics, and Molecular medicine.

Reasons to attend the Proteomics Conference 2023

Being active on social media, we often forget the importance of facing people face-to-face. There is power in being connected with the experts who are active in your line of work. You will get the opportunity to network with scientists, professors, researchers, and many such professionals at our conference.

Here are the benefits of attending the Proteomics Conference 2023

Find out new trends in the field of Proteomics, Genomics, Molecular Biology, biotechnology, and medicine.
Network with the world's best experts.
Added research value.
Establish yourself.
Crack the comfort zone.
CPD Certification.
Participation Certificate by IOCM.